Clover Health Investments, Corp.
CLOV
$2.00
-$0.07-3.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.66% | 31.76% | 21.89% | 15.34% | 8.20% |
| Total Other Revenue | 23.24% | 50.38% | 36.27% | 33.21% | 28.61% |
| Total Revenue | 40.33% | 32.09% | 22.12% | 15.62% | 8.52% |
| Cost of Revenue | 55.85% | 38.00% | 22.54% | 10.01% | 0.17% |
| Gross Profit | -2.53% | 13.92% | 20.78% | 34.80% | 40.96% |
| SG&A Expenses | 7.53% | 7.44% | 2.79% | -0.62% | -7.11% |
| Depreciation & Amortization | 26.67% | -3.07% | -17.88% | -41.95% | -46.95% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.82% | 29.22% | 16.72% | 6.78% | -2.12% |
| Operating Income | -86.22% | 22.55% | 56.27% | 81.13% | 75.08% |
| Income Before Tax | -84.91% | 37.77% | 64.17% | 84.14% | 77.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.91% | 37.77% | 64.17% | 84.14% | 77.98% |
| Earnings from Discontinued Operations | -- | -145.56% | 84.03% | 88.22% | 201.37% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.91% | 36.18% | 65.16% | 84.30% | 79.84% |
| EBIT | -86.22% | 22.55% | 56.27% | 81.13% | 75.08% |
| EBITDA | -88.00% | 22.99% | 57.02% | 81.92% | 75.47% |
| EPS Basic | -89.41% | 38.79% | 66.12% | 84.64% | 80.24% |
| Normalized Basic EPS | -77.00% | 25.73% | 57.47% | 81.53% | 75.56% |
| EPS Diluted | -79.78% | 40.28% | 66.73% | 83.23% | 79.18% |
| Normalized Diluted EPS | -76.40% | 25.88% | 57.54% | 81.41% | 75.48% |
| Average Basic Shares Outstanding | 4.10% | 3.34% | 2.68% | 2.01% | 1.85% |
| Average Diluted Shares Outstanding | 3.69% | 2.94% | 2.27% | 2.41% | 2.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |